Home / Import refusals / AEK-8269206-0/11/1

FDA Import Refusal AEK-8269206-0/11/1 — Novo Nordisk Inc.

Novo Nordisk Inc. — FEI 2244771

The FDA refused shipment AEK-8269206-0/11/1 from Novo Nordisk Inc. (United States) on April 6, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 6, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1255957 (OAI Fri Feb 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1194065 (NAI Wed Dec 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1013344 (VAI Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983531 (NAI Fri Jul 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 968597 (NAI Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 1FX-4157426-0/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0725103-5/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5519360-0/10001/1 (Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0407174-1/20002/1 (Wed Jun 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0407174-1/10002/1 (Wed Jun 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources